|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 553.48 USD | +1.46% |
|
+3.13% | -4.96% |
| 07-13 | Madrigal Pharmaceuticals' Three New Patents Support Patent Extension Into 2045, Truist Says | MT |
| 07-13 | Madrigal Pharmaceuticals Expands Rezdiffra Patent Protection With Three New Patents | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 565.4 | 565.4 | 598.91 |
| Spread/Res. | -2.11% | -2.11% | -7.59% |
| Spread/Supp. | +7.60% | +11.36% | +32.13% |
| Support | 514.39 | 497.03 | 418.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MDGL Stock
- Charts Madrigal Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
